News & Trends - MedTech & Diagnostics
Ramsay Health Care to build $133m private hospital in Melbourne

MedTech News: Ramsay Health Care has committed to constructing and operating a new $133m greenfield private hospital in Victoria to service one of the fastest growing populations in Australia.
Northern Private Hospital will be built in Epping, which is the last major growth corridor in Victoria without a private hospital. It will be co-located with a 500-bed public hospital to ensure patients have access to a comprehensive range of health care services.
Northern Private Hospital will be built on land adjacent to the Northern Hospital, which has one of the busiest emergency departments in the state and is itself undergoing a major rebuilding and refurbishment project.
The new Northern Private Hospital will deliver extensive medical, surgical and mental health services. Patients will be able to access a broad range oftreatments in specialties such as general medicine, cardiology, vascular, orthopaedics, plastics, ENT, general surgery, gynaecology, urology, oncology, haematology, ophthalmology and gastroenterology.
The Victorian Government has also supported the construction of a link bridge to connect the private and public hospitals for ease of access between the two facilities.
Ramsay plans to open Northern Private Hospital in two stages, with the first stage to be completed in 2024 and the second stage forecast to open in 2027.
Ramsay Health Care Australia’s Chief Business Development Officer, Alex Belcastro, said this exciting announcement is the culmination of three years of extensive planning and approvals.
“This development is widely considered to be the most meaningful greenfield growth opportunity in Victoria and will offer patients in Melbourne’s northern suburbs access to high-quality health care in a private setting close to their homes,” Ms Belcastro said.
“The City of Whittlesea’s population is forecast to grow by 71% between 2018 and 2041, so this will provide much-needed treatment options for people living in these communities.”
News & Trends - Pharmaceuticals

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines
Over a third of Australian adults live with obesity, and the National Obesity Strategy estimates the direct and indirect costs […]
MoreNews & Trends - Pharmaceuticals

Astellas secures new indication for prostate cancer drug
Astellas Xtandi (enzalutamide) is now TGA registered for a new indication for patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with […]
MoreNews & Trends - MedTech & Diagnostics

Stakeholder calls intensify as government stalls on genetic discrimination ban
Calls have intensified for the federal government to honour its commitment to outlaw genetic discrimination in life insurance, as stakeholders […]
MoreNews & Trends - MedTech & Diagnostics

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day
As Australia marks World Kidney Day, the stark reality is that one in three adults is at risk of chronic […]
More